1-(Boc-amino)-3-fluorocyclobutane-1-methylamine

Catalog No.: 
ACHALY985
CAS No.: 
1363382-95-9
Molecular Formula: 
C10H19FN2O2
Molecular Weight: 
218.27
1-(Boc-amino)-3-fluorocyclobutane-1-methylamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$185.00InquiryInquiry
250mg95%$368.00InquiryInquiry
1g95%$1169.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Boc-amino)-3-fluorocyclobutane-1-methylamine
IUPAC Nametert-butyl (1-(aminomethyl)-3-fluorocyclobutyl)carbamate
MDL No.MFCD22566205
Molecular FormulaC10H19FN2O2
Molecular Weight218.27
SMILESNCC1(NC(OC(C)(C)C)=O)CC(F)C1
InChI KeyDYSWSFKAIZTAJQ-UHFFFAOYSA-N
Synonym1-(Boc-amino)-3-fluorocyclobutane-1-methylamine;tert-butyl N-[1-(aminomethyl)-3-fluorocyclobutyl]carbamate;Carbamic acid, N-[1-(aminomethyl)-3-fluorocyclobutyl]-, 1,1-dimethylethyl ester;1-(Aminomethyl)-N-Boc-3-fluorocyclobutanamine;tert-butyl (1-(aminomethyl)-3-fluorocyclobutyl)carbamate
CAS No.1363382-95-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACHALY985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHALY985 route product structure diagram
    ACHALY9851363382-95-9
Inquiry

2. ACHALY985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHALY985 route product structure diagram
    ACHALY9851363382-95-9
Inquiry

3. ACHALY985 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHALY985 route product structure diagram
    ACHALY9851363382-95-9
Inquiry

Comments (0)